MEDICAL MANAGEMENT OF METASTATIC SKELETAL DISEASE

Adami, 1997, Bisphosphonates in prostate carcinoma, Cancer, 80, 1674, 10.1002/(SICI)1097-0142(19971015)80:8+<1674::AID-CNCR18>3.0.CO;2-X Berenson, 1997, Bisphosphonates in multiple myeloma, Cancer, 80, 1661, 10.1002/(SICI)1097-0142(19971015)80:8+<1661::AID-CNCR16>3.0.CO;2-Y Body, 1996, Use of bisphosphonates in cancer patients, Cancer Treat Rev, 22, 265, 10.1016/S0305-7372(96)90020-1 Breitbart, 1990, Psychiatric aspects of cancer pain., 73 Breitbart, 1998, Pain., 450 Cleeland, 1994, Pain and its treatment in outpatients with metastatic cancer, N Engl J Med, 330, 592, 10.1056/NEJM199403033300902 Diel, 1998, Reduction in new metastases in breast cancer with adjuvant clodronate treatment, N Engl J Med, 339, 357, 10.1056/NEJM199808063390601 Kanner, 1981, Patterns of narcotic use in a cancer pain clinic, Ann NY Acad Sci, 362, 161, 10.1111/j.1749-6632.1981.tb12804.x Lipton, 1998, Aredia: The once-monthly infusion for the treatment of bone metastases, Curr Opin Oncol, 10, S1 Lipton, 1997, Bisphosphonates and breast carcinoma, Cancer, 80, 1668, 10.1002/(SICI)1097-0142(19971015)80:8+<1668::AID-CNCR17>3.0.CO;2-Y Mirels, 1989, Metastatic disease in long bones: A proposed scoring system for diagnosing impending pathologic fractures, Clin Orthop, 249, 256, 10.1097/00003086-198912000-00027 Mundy, 1999, Bisphosphonates as cancer drugs, Hosp Prac, 34, 81, 10.3810/hp.1999.05.141 Mundy, 1998, Bisphosphonates as anticancer drugs, N Engl J Med, 339, 398, 10.1056/NEJM199808063390609 Twycross, 1983 Ward, 1999, Orthopaedic oncology for the nononcologist orthopaedist: Introduction and common errors to avoid, Instr Course Lect, 48, 577